leisure time -WSS

leisure time

author：hotspot 2025-09-28 00:53:56 - browse：678

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Faced with fears of OxyContin misuse, sales reps touted its safety

explore

WSS

Hospitals consider fixing cancer drug shortages on their own

How housing is health care on Long Island

Genentech weighs delaying cancer therapy after drug pricing law

How medical schools plan to diversify without affirmative action

How medical schools plan to diversify without affirmative action

FDA proposes changes to key medical devices approval pathway

hotspot

leisure time

entertainment

What does generative AI mean for health care? We asked experts

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Medicare details structure of new drug price negotiation program

Faced with fears of OxyContin misuse, sales reps touted its safety

Novavax promises a turnaround & Lilly roils the obesity market

Telehealth for opioid use disorder is lifesaving

How to save PrEP access — and even expand it

Listen: Your guide to Wegovy's blockbuster heart study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

focus

White House drug shortages task force keeps mum with Congress

Popular nasal decongestant doesn't actually relieve congestion

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Genentech weighs delaying cancer therapy after drug pricing law

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Faced with fears of OxyContin misuse, sales reps touted its safety

entertainment

hotspot

explore

knowledge